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Abstract.  
Objective. Irritability is a common reason for referral to services, strongly associated with 
impairment and negative outcomes, but is a nosological and treatment challenge. A major issue 
is how irritability should be conceptualized. This study used a developmental approach to test 
the hypothesis that there are several forms of irritability, including a 
‘neurodevelopmental/ADHD-like’ type with onset in childhood and a ‘depression/mood’ type 
with onset in adolescence. Method. Data were analyzed in the Avon Longitudinal Study of 
Parents and Children, a prospective UK population-based cohort. Irritability trajectory-classes 
were estimated for 7924 individuals with data at multiple time-points across childhood and 
adolescence (4 possible time-points from approximately ages 7 to 15 years). Psychiatric 
diagnoses were assessed at approximately ages 7 and 15 years. Psychiatric genetic risk was 
indexed by polygenic risk scores (PRS) for attention-deficit/hyperactivity disorder (ADHD) and 
depression derived using large genome-wide association study results. Results. Five irritability 
trajectory classes were identified: low (81.2%), decreasing (5.6%), increasing (5.5%), late-
childhood limited (5.2%) and high-persistent (2.4%). The early-onset, high-persistent trajectory 
was associated with male preponderance, childhood ADHD (OR=108.64 (57.45-204.41), 
p<0.001) and ADHD PRS (OR=1.31 (1.09-1.58), p=0.005); the adolescent-onset, increasing 
trajectory was associated with female preponderance, adolescent depression (OR=5.14 (2.47-
10.73), p<0.001) and depression PRS (OR=1.20, (1.05-1.38), p=0.009). Both trajectory classes 
were associated with adolescent depression diagnosis and ADHD PRS. Conclusions. The 
developmental context of irritability may be important in its conceptualization: early-onset 
persistent irritability maybe more ‘neurodevelopmental/ADHD-like’ and later-onset irritability 
more ‘depression/mood-like’. This has implications for treatment as well as nosology. 
Keywords. ALSPAC; irritability; longitudinal; trajectories; genetic; polygenic risk scores  
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Identifying novel types of irritability using a developmental genetic approach  
Irritability – a heightened propensity to anger, relative to peers – is a common reason for 
referral to mental health services, is strongly associated with impairment and long-term 
adverse outcomes (1-6), yet remains a nosological and treatment challenge (1, 2). Currently, it is 
treated as a homogenous construct, but it is a core or accompanying feature of several 
psychiatric disorders and such differential associations suggest that subtyping may be 
necessary. This study set out to examine the possibility that there are multiple forms of 
irritability, including a ‘neurodevelopmental’ type with onset in childhood and a 
‘depression/mood’ type with onset in adolescence.  
Childhood irritability has typically been considered a feature of Oppositional Defiant Disorder 
(ODD) (7) - in the forthcoming ICD-11 it is likely to be considered a specifier of ODD. However 
irritability has been shown to be distinct from other ODD dimensions (headstrong, hurtful) in 
that it shows phenotypic and genetic associations with unipolar depression (5, 8). The DSM-5 
has categorized severe, chronic childhood irritability as Disruptive Mood Dysregulation 
Disorder (DMDD) and grouped it with the mood disorders (9). ICD-11 and DSM-5 also include 
irritability as a diagnostic symptom of depression in children and adolescents (for dysthymic 
disorder specifically in ICD-11). 
Yet irritability – and, more broadly, emotional dysregulation – is an especially common feature 
of attention-deficit/hyperactivity disorder (ADHD), which is grouped as a neurodevelopmental 
disorder under DSM-5. Irritability prevalence rates of 91% have been reported in children with 
the disorder (10). Evidence of clinical overlap between irritability and ADHD (11, 12), genetic 
overlap with ADHD, as well as features such as its manifestation in early development and male 
preponderance also have led recently to the suggestion that irritability should perhaps be 
conceptualized as a neurodevelopmental/ADHD-like problem, rather than a mood problem 
(12).  
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Two differentiating factors between neurodevelopmental and mood problems are 
developmental course and sex preponderance. Neurodevelopmental problems typically onset 
early, decline across childhood/adolescence and are more common in males, while mood 
problems tend to onset in adolescence and are more common in females (13). A developmental 
approach may therefore help towards better establishing whether irritability it is more 
appropriately conceptualized as a mood or neurodevelopmental problem.  
One possibility is that irritability is a heterogeneous construct; there may be different “types” of 
irritability, including a neurodevelopmental/ADHD-like irritability and a mood/depression-like 
irritability. Consistent with this premise, a recent population-based, cross-sectional 
investigation of irritability symptoms observed different developmental patterns for males and 
females: irritability was more common in boys during childhood (and levels tended to decrease 
with age) while irritability was more common in girls in adolescence (levels tended to increase 
with age) (12). These findings are consistent with there being two “types” of irritability; one 
that onsets early and is more common in boys (a pattern typical of neurodevelopmental 
problems) and another “type” that starts in adolescence and is more common in girls (a pattern 
typical of mood problems). To our knowledge age-at-onset in childhood compared to 
adolescence has not previously been investigated as a possible source of heterogeneity in 
irritability.  
The aim of this study was to take advantage of a longitudinal population-based cohort and use a 
developmental approach to test the hypothesis that there are at least two forms of irritability: 
one ‘neurodevelopmental/ADHD-like’ type with onset in childhood and one ‘depression/mood’ 
type with onset in adolescence. Specifically, we used a latent growth modelling approach to test 
the following hypotheses suggested by this formulation of irritability: (a) an irritability 
trajectory defined by an early age-at-onset would be associated with male sex, ADHD genetic 
liability as indexed by ADHD genetic risk scores (polygenic risk scores: PRS) and a higher rate of 
diagnosis of ADHD in childhood, and (b) an irritability trajectory defined by an age-at-onset 
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around early-mid adolescence would be associated with female sex, depression genetic liability 
as indexed by depression genetic risk scores, and a diagnosis of depression in adolescence.  
Method 
Sample 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a well-established 
prospective, longitudinal birth cohort study. The enrolled core sample consisted of 14,541 
mothers living in Avon, England, who had expected delivery dates of between 1st April 1991 and 
31st December 1992. Of these pregnancies 13,988 children were alive at 1 year. When the oldest 
children were approximately 7 years of age, the sample was augmented with eligible cases who 
had not joined the study originally, resulting in enrollment of 713 additional children. The 
resulting total sample size of children alive at 1 year was N=14,701. Genotype data were 
available for 8,365 children following quality control. Ethical approval for the study was 
obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics 
Committees. Full details of the study, measures and sample can be found elsewhere (14, 15). 
Please note that the study website contains details of all the data that is available through a fully 
searchable data dictionary (http://www.bris.ac.uk/alspac/researchers/data-access/data-
dictionary). Where families included multiple births, we included the oldest sibling.  
Analyses were conducted including participants with at least two time-points of irritability data 
(see below) (N=7924): further details of sample sizes for available data are shown in 
Supplementary Figure 1.  
Irritability 
In-line with previous work (7) irritability was defined using parent-reported data from the 
oppositional defiant disorder (ODD) section of the Development and Well-Being Assessment 
(DAWBA)(16) - a structured research diagnostic interview - at ages 7 years 7 months, 10 years 
7 
 
8 months, 13 years 10 months and 15 years 6 months. For the first 3 assessments, the parent 
version of the DAWBA was sent to mothers in a package of postal measures. For the final 
assessment, mothers independently completed the same version of the DAWBA in the ALSPAC 
clinic. Irritability in the last six months was measured by three items (severe temper tantrums, 
touchy and easily annoyed, angry and resentful) rated on a 3-point scale (no more than others; a 
little more than others; a lot more than other) and summed to give a total score (0-6). 
Distributions and descriptive statistics are shown in Supplementary Table 1. 
Diagnoses 
The DAWBA (16) was also used to assess ADHD, ODD (which included the irritability items), 
conduct disorder (CD), general anxiety disorder (GAD) and depression. In childhood (age 7 
years 7 months) parent-reports were used. In adolescence (15 years 6 months) parent-reports 
were used to assess ADHD, ODD and CD; self-reports were used to assess GAD and depression. 
DSM-IV diagnoses were generated using computer generated diagnoses (17); no diagnoses 
were mutually exclusive. 
Genetic liability 
Polygenic risk scores (PRS) were used to capture common variant genetic liability for two 
disorders - depression and Attention Deficit Hyperactivity Disorder (ADHD). For each disorder, 
PRS were generated as the weighted mean number of disorder risk alleles in approximate 
linkage equilibrium (r-square<0.1), derived from imputed autosomal SNPs using PRSice (18) 
(N=5559 of those included in this study: see Supplementary Figure 1). Sensitivity analyses were 
conducted using inverse probability weighting (19) to assess the impact of missing data (see 
Supplementary Material). Risk alleles were defined as those associated with case-status from 
the latest genome-wide association studies of depression (135,458 cases and 344,901 controls) 
(20) and ADHD (19,099 cases and 34,194 controls) (21). The depression GWAS sample 
consisted of adults with depression although affected individuals had varying ages-at-onset (e.g. 
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22). Individuals in the ADHD GWAS sample all had ADHD that by definition has onset in 
childhood. Primary analyses defined risk alleles as those associated at a threshold of p<0.05; 
associations across a range of p-thresholds are shown in Supplementary Figure 2. Scores were 
standardized using Z-score transformation. Genotyping details as well as full methods for 
generating the PRS are presented in the Supplementary Material. 
Analyses 
Growth mixture modelling (GMM) was conducted to identify developmental trajectories of 
irritability across ages 7 to 15 years in Mplus (23). GMM aims to group individuals into 
categories (trajectories) based on patterns of change across multiple time-points, with 
individuals within each category assumed to have the same growth curve (24). Thus, differing 
levels of irritability are captured based on observed differences (i.e. data-driven) rather than 
based on cut-points, in-line with evidence supporting liability to psychiatric problems being 
continuously distributed (25). Starting with a single k-class solution, k+1 solutions are fitted 
until the optimum solution is reached. Models were run using a robust maximum likelihood 
parameter estimator (MLR) and full information maximum likelihood (FIML) estimation (26). 
As recommended, the optimal number of categories was determined by interpretability as well 
as model fit indices (see Supplementary Material)(24). Following identification of the irritability 
trajectories, to test associations with PRS, sex and diagnoses and to estimate/compare 
prevalence rates, analyses were conducted in Mplus, using a bias-free three step approach 
which accounts for measurement error in class assignment (27); multinomial odds ratios are 
reported. Inverse probability weighting (19) was used to assess the impact of missing genetic 
data, which weights observations based on measures assessed in pregnancy that were 
predictive of variables in the analysis and/or inclusion in the subsample with genetic data (see 
Supplementary Material). Sensitivity analyses were conducted including sex as a covariate. 
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Results 
Irritability trajectories 
We identified a five-class solution (see Supplementary Material), characterized by distinct 
irritability trajectory classes: low (81.2%), decreasing (5.6%), increasing (5.5%), late-childhood 
limited (5.2%) and high-persistent (2.4%), shown in Figure 1. 
A male preponderance was observed for the decreasing, late-childhood limited and high-
persistent trajectory classes (55.7%, 55.7% and 63.7% male respectively) and a female 
preponderance for the increasing trajectory class (40.5% male). Accordingly, male sex was 
associated with an increased likelihood of being in the decreasing (OR=1.27(1.01-1.59), 
p=0.038), late-childhood limited (OR=1.37 (1.09-1.73), p=0.007) or high-persistent classes 
(OR=1.76 (1.30-2.40), p<0.001) and a decreased likelihood of being in the increasing trajectory 
(OR=0.68 (0.54-0.87), p=0.002) compared to the low trajectory class (49.8% male). 
Genetic risk  
Associations between irritability trajectory classes and ADHD PRS and depression PRS are 
shown in Table 1. Mean PRS for each of the trajectory classes are shown in Figure 2. Compared 
to the low trajectory class, ADHD PRS were associated with an increased likelihood of being in 
both the high-persistent (OR=1.31 (95% CI 1.09-1.58), p=0.005) and increasing (OR=1.28 (95% 
CI 1.11-1.48), p=0.001) trajectory classes, with a similar risk of being in either trajectory (high-
persistent vs. increasing OR=1.02 (95% CI 0.81-1.29), p=0.854).  
Depression PRS were associated with an elevated likelihood of being in the increasing trajectory 
class compared to the low trajectory class (OR=1.20 (95% CI 1.05-1.38), p=0.009), although 
evidence for an elevated likelihood of being in the increasing trajectory class compared to the 
high-persistent trajectory class was weaker (OR=1.20 (95% CI 0.96-1.52), p=0.116). 
10 
 
Multivariable analyses including both PRS in the same model revealed the same pattern of 
results (see Table 1 vs. Supplementary Table 3) as did sensitivity analyses using inverse 
probability weighting to assess the impact of missing genetic data (Supplementary Table 4). 
Diagnoses 
Estimated prevalence rates of ADHD, depression, GAD, ODD and CD in childhood and 
adolescence are shown in Tables 2 and 3. Rates of all diagnoses varied across the irritability 
trajectory classes, with the exception that there was not strong evidence of variation in 
adolescent GAD across classes. At both developmental stages, rates of all diagnoses were 
generally highest in the high-persistent trajectory and were particularly high for ODD.  
Childhood ADHD. Childhood ADHD was associated with an increased likelihood of being in the 
decreasing (OR=30.97 (15.47-61.98), p<0.001) increasing (OR=5.89 (1.96-17.73), p=0.002), 
late-childhood limited (OR=20.39 (9.78-42.52) p<0.001) and the high-persistent (OR=108.64 
(57.45-204.41), p<0.001) compared to the low trajectory class.  
Comparing these four irritability trajectories, childhood ADHD was associated with a decreased 
likelihood of being in the increasing trajectory class (compared to decreasing OR=0.19 (0.07-
0.52), p=0.001; late-childhood limited OR=0.29 (0.10-0.84), p=0.023; high-persistent OR=0.05 
(0.02-0.15), p<0.001) and with the greatest likelihood associated with the high-persistent 
classes (compared to decreasing OR=3.50 (2.09-5.87), p<0.001; late-childhood limited OR=5.33 
(2.92-9.73), p<0.001). 
Adolescent depression. Compared to the low trajectory class, an increased likelihood of 
adolescent depression was found for the increasing (OR=5.14 (2.47-10.73), p<0.001) and high-
persistent (OR=7.18 (3.10-16.61), p<0.001) trajectory classes (decreasing class OR=2.32 (0.88-
6.12), p=0.088; late-childhood limited class OR=1.95 (0.63-6.04), p=0.250). Likelihood of 
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adolescent depression was similar for the high-persistent compared to the increasing trajectory 
class (OR=1.40 (0.51-3.84), p=0.516).  
Sensitivity analyses 
Controlling for sex revealed the same pattern of results for both PRS and diagnoses 
(Supplementary Tables 5 and 6); mean PRS and estimated prevalence rates for diagnoses by sex 
are shown in Supplementary Figures 3 and 4).  
Discussion 
This study aimed to investigate developmental trajectories of irritability across childhood and 
adolescence to test the hypothesis that there are different forms of ‘neurodevelopmental’ and 
‘depression/mood’ irritability. Specifically we hypothesized that a ‘neurodevelopmental/ADHD-
like’ irritability trajectory would be defined by an early age-at-onset, a male preponderance and 
would be associated with an increased genetic liability to ADHD and ADHD diagnosis in 
childhood, whereas a ‘depression/mood’ irritability trajectory would be defined by a later age-
at-onset, a female preponderance, and would be associated with increased genetic liability to 
depression and depression diagnosis in adolescence.  
We identified five distinct developmental trajectory classes of irritability across childhood and 
adolescence. Four classes were characterized by elevated levels of irritability during at least 
some of this developmental period. Two irritability trajectory classes were early-onset: one was 
defined by symptoms that decreased over time and the other by high symptoms that persisted 
(5.6% and 2.4% of the sample respectively). These two groups show very similar 
developmental patterns to ADHD; with some individuals showing persistence over time and 
others remitting. An additional unexpected trajectory with irritability onset in late childhood 
was defined by an increase in symptoms at around age 10 years and a subsequent decrease at 
around age 13 years (5.2% of the sample). That is the age of high school transition in the UK as 
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well as the onset of puberty for many but we can only speculate as to the underlying 
mechanisms for this class as this group has not been previously described. The final trajectory 
was defined by increasing symptoms that showed a later onset, around adolescence (5.5% of 
the sample). 
In line with our first hypothesis, the two irritability trajectories with early-onset (decreasing 
and high-persistent) were both associated with male sex and ADHD diagnosis in childhood, as 
was the late-childhood onset (late-childhood limited) class. The high-persistent trajectory was 
also associated with increased ADHD genetic risk scores - although the childhood-onset 
trajectories that did not have persistent symptoms (decreasing and late-childhood limited) 
were not. This is similar to findings on the developmental patterns of ADHD symptoms, that 
those with persistent compared to childhood-limited symptoms of ADHD have an increased 
genetic liability to ADHD (28). An association between irritability and ADHD PRS has been 
observed previously in the total sample as well as a clinical sample and accords with an earlier 
twin study that observed shared genetic links between ADHD and emotional lability (11, 12). 
Interestingly, the later-onset (increasing) irritability trajectory was also associated with ADHD 
PRS – although rates of childhood ADHD diagnosis were low. It may be that the phenotypic 
expression of ADHD genetic liability in this predominantly female group manifests as mood 
problems (see 29), although further work would be needed to investigate this. Our findings 
therefore support the suggestion of a neurodevelopmental/ADHD-like ‘type’ of irritability, 
which onsets early, has a male preponderance and is associated with ADHD. 
In line with our second hypothesis, the trajectory with irritability onset in adolescence (the 
increasing trajectory class) was associated with female sex. This ‘depression/mood-type’ 
irritability trajectory class was also associated with depression genetic risk scores and 
depression diagnosis in adolescence. This class was also associated with ADHD genetic risk 
scores. Although twin work had indicated genetic overlap between irritability and depression, 
previous analyses of this same sample had failed to observe association between irritability 
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with depression genetic risk scores (8, 30). This raised questions about the primary 
classification of severe irritability as a mood problem. Indeed it appears that ICD-11 is going to 
take a different approach to DSM-5 and conceptualize irritability as a specifier of ODD, and not 
include severe irritability / disruptive mood dysregulation disorder as a mood disorder (the 
approach taken by DSM-5). ICD-11 does however now include irritability as an alternative 
symptom to depressed mood for dysthymic disorder for children and adolescents (a similar 
approach to that used by DSM-5 for depression). Our findings suggest that the association 
between irritability and depression genetic risk scores may be specific to a type of irritability 
that onsets during adolescence.  
Regardless of whether the DSM-5 or ICD-11 stance to dealing with severe irritability is most 
valid, neither have taken a developmental approach. Our findings suggest that development 
matters. This view is not new (see 31) and has been applied to other phenotypes including anti-
social behavior (32) but perhaps has been forgotten because it poses substantial challenges to 
clinicians and researchers. A transdiagnostic conceptualization of irritability such as that used 
by R-DoC, or the “p-factor” framework (33), could provide a helpful research framework for 
conceptualizing irritability dimensionally across multiple levels. Our study suggests that if such 
a framework were to be implemented, it should be developmentally informed, taking into 
account age (and age-at-onset). 
In terms of how the trajectory classes relate to psychiatric diagnoses, diagnostic rates are 
relatively low because this is a population-based cohort; nevertheless, there are some notable 
observations. Interestingly, while the high-persistent ‘neurodevelopmental/ADHD-like’ 
irritability trajectory class was not associated with depression PRS, this class showed a similar 
risk of adolescent depression as the increasing ‘depression/mood-like’ irritability trajectory. 
Thus both trajectory classes are associated with risk of depression in adolescence, although the 
mechanisms of this associations are likely different, for example increased risk for depression in 
the early-onset irritability type may be driven by environmental factors, such as increased life 
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events associated with irritability, rather than genetic risk for depression - although further 
work into this would be needed. It is established that child neurodevelopmental disorders such 
as ADHD, as well as oppositional defiant disorder and conduct problems, are risk factors for 
later depression so it is perhaps unsurprising that the ‘neurodevelopmental’ irritability 
trajectory is also associated with depression, although emerging research suggests that the 
presence of irritability in those with ADHD confers additional risk of depression (34).  
Consistent with previous work (2) we found elevated rates of other psychiatric disorders in 
those with elevated irritability. Rates of ODD were particularly high in the elevated irritability 
trajectory classes and followed a similar developmental pattern to irritability levels. This is 
unsurprising given that irritability is a core component of ODD, indeed irritability was defined 
by terms from the ODD section of the DAWBA instrument. However a large proportion (39-
99%) of individuals in the elevated irritability trajectory classes did not have ODD, suggesting 
that irritability in those without ODD is also important and adds to the idea that irritability is 
transdiagnostic. Interestingly, despite previous work findings associations between irritability 
and anxiety as well as depression (2), we did not find strong evidence that the rates of GAD in 
adolescence differed between those in each of the irritability trajectory classes. Previous 
research on links between irritability and depression has often included anxiety symptoms in 
the same measure (30), or found the same pattern of results for depression and anxiety (6). Our 
findings suggest specificity to depression in adolescence.  
One explanation for the apparent existence of different irritability “types” is that irritability is 
simply a feature of different underlying diagnoses (e.g. depression and ADHD). However the low 
rates of those diagnoses in the population-based trajectory classes (see Tables 2 and 3) suggest 
this is not the case (e.g. only a small minority of those in the increasing irritability trajectory 
class had a diagnosis of depression) and associations with PRS were similar when excluding 
those with diagnoses (Supplementary Table 7). Also, sex differences for the early-onset, 
persistent and increasing irritability trajectory classes were not as pronounced as typically 
15 
 
reported for depression and ADHD (35). These observations suggest that the different 
irritability “types” are not simply a feature of different underlying diagnoses (ADHD and 
depression).  
Our findings should be considered in light of some limitations. First, ALSPAC is a longitudinal 
birth cohort study that suffers from non-random attrition and those with increased genetic 
liability to disorder and with higher levels of psychopathology are more likely to drop out of the 
study (36, 37). However, our trajectory analyses used full information maximum likelihood 
(FIML) estimation (26) so that complete data on irritability were not required. Moreover, 
inverse probability weighted (IPW) analyses suggested that missingness of genetic data did not 
have a large effect on our findings. It is possible that associations between depression PRS and 
(increasing) irritability were inflated by some of the cases in the depression GWAS having 
(adolescent-onset) irritability as a symptom. Also, while PRS are useful indicators of genetic 
liability, ADHD and depression PRS currently explain a minority of common variant liability to 
the disorder (20, 21). Our analyses were therefore underpowered to detect associations 
between PRS and irritability trajectories: our analyses had 80% power to detect odds ratios of 
1.35 for the increasing trajectory and 1.60 for the high-persistent trajectory (38). Thus while the 
effect sizes we observed are in-line with similar types of analyses reported elsewhere (39), PRS 
regarded as indicators of genetic liability rather than as predictors of psychopathology. We 
deliberately elected to use depression PRS derived from adult samples that reflect ‘typical’ 
depression. Pre-pubertal/childhood depression is rare and considered to be atypical not only in 
age of onset but also in terms of other features (e.g. 40). The associations that we observe 
between adolescent-onset irritability and depression PRS are therefore consistent with 
previous work showing associations between irritability and adolescent/adult depression. 
We did not include covariates in our analyses of ADHD and MDD diagnoses as we were 
interested in describing observed associations: this means that we cannot infer any causal 
associations between irritability and diagnoses. Different methods such as Mendelian 
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randomization (MR) would be needed to investigate such research questions (41). Finally, our 
aim was to use a developmental approach to investigate nosology. However diagnostic and 
subgroup overlap is the rule in Psychiatry and this study was no exception. Our 
‘neurodevelopmental/ADHD-like’ and ‘depression/mood-like’ irritability classes were both 
associated with ADHD and depression diagnoses and ADHD genetic risk scores. We observed 
different patterns for these classes rather than identifying completely distinct groups. Finally, 
there are difficulties in determining the optimum number of classes using growth mixture 
modelling. Given this is the first study to our knowledge to investigate irritability trajectories 
across childhood and adolescence, we emphasize that further research is needed in this area 
that includes testing the replicability of these trajectories in different samples. 
In conclusion, our study identified different developmental trajectories of irritability including 
one with characteristics typical of neurodevelopmental/ADHD-like problems - early-onset, male 
preponderance and clinical and genetic links with ADHD - and one with characteristics typical of 
depression/mood problems - later-onset, female preponderance and clinical and genetic links 
with depression. Both groups were associated with risk of adolescent depression; both were 
associated with ADHD genetic risk scores. Overall the findings suggest that the developmental 
context of irritability may be important in its conceptualization; that has implications for 
treatment as well as nosology (2).   
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Table 1. Association between ADHD and depression genetic risk scores and irritability 
trajectories 
 ADHD PRS Depression PRS 
 OR 95% CI p OR 95% CI p 
Childhood-onset irritability       
  Decreasing 1.06 (0.92, 1.22) 0.425 1.12 (0.97, 1.29) 0.126 
  Late-childhood limited 1.14 (0.99, 1.32) 0.071 0.93 (0.82, 1.06) 0.266 
  High-persistent 1.31 (1.09, 1.58) 0.005 1.00 (0.82, 1.21) 0.992 
Adolescent-onset irritability       
  Increasing 1.28 (1.11, 1.48) 0.001 1.20 (1.05, 1.38) 0.009 
Low trajectory as reference. ADHD=attention-deficit/hyperactivity disorder, PRS = polygenic 
risk score 
 
Table 2. Estimated prevalence of diagnoses in childhood across irritability trajectories 
 ADHD 
(N=7043) 
Depression 
(N=6947) 
GAD 
(N=7029) 
ODD 
(N=7034) 
CD 
(N=6979) 
  Low 0.3% (0.1) 0.1% (0.1) 0.0% (0.0) 0.1% (0.1) 0.0% (0.0) 
Childhood onset irritability 
  Decreasing 9.3% (1.6) 5.7% (1.2) 1.1% (0.6) 28.3% (2.5) 4.0% (1.1) 
  Late-childhood limited 6.3% (1.4) 0.7% (0.5) 0.5% (0.4) 5.9% (1.5) 1.0% (0.6) 
  High-persistent 26.4% (3.4) 4.2% (1.6) 3.6% (1.4) 51.0% (3.9) 11.7% (2.5) 
Adolescent onset irritability 
  Increasing 1.9% (0.9) 0.0% (0.0) 0.0% (0.0) 0.6% (0.7) 0.2% (0.3) 
χ2(4) 122.64 
p<0.001 
45.68 
p<0.001 
14.92 
p=0.005 
342.50 
p<0.001 
43.22 
p<0.001 
Standard errors in parentheses. ADHD=attention-deficit/hyperactivity disorder, 
GAD=generalised anxiety disorder, ODD=oppositional defiant disorder, CD=conduct disorder 
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Table 3. Estimated prevalence of diagnoses in adolescence across irritability trajectories 
 ADHD 
(N=4500) 
Depression 
(N=4900) 
GAD 
(N=4896) 
ODD 
(N=4490) 
CD 
(N=4489) 
  Low 0.2% (0.1) 1.1% (0.1) 0.4% (0.1) 0.1% (0.1) 0.1% (0.1) 
Childhood onset irritability 
  Decreasing 1.7% (0.9) 2.5% (1.1) 0.8% (0.6) 2.1% (1.2) 1.1% (0.8) 
  Late-childhood limited 0.6% (0.8) 2.1% (1.1) 0.8% (0.7) 1.1% (1.5) 0.7% (1.0) 
  High-persistent 14.2% (3.4) 7.3% (2.6) 3.1% (1.8) 60.9% (5.1) 17.4% (3.8) 
Adolescent onset irritability 
  Increasing 7.3% (1.9) 5.3% (1.6) 2.9% (1.2) 46.0% (3.9) 17.0% (2.7) 
χ2(4) 43.83 
p<0.001 
15.34 
p<0.001 
7.51 
p=0.111 
325.23 
p<0.001 
76.93 
p<0.001 
Standard errors in parentheses. ADHD=attention-deficit/hyperactivity disorder, 
GAD=generalised anxiety disorder, ODD=oppositional defiant disorder, CD=conduct disorder
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Figure 1. Irritability trajectories by class 
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Figure 2. Mean ADHD and depression genetic risk score by irritability trajectories, with 95% confidence intervals 
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Supplementary Material 
Generating polygenic risk scores 
In total 9912 ALSPAC children were genotyped using the Illumina HumanHap500-quad 
genotyping array. Individuals were excluded on the basis of gender mismatches; minimal or 
excessive heterozygosity, disproportionate levels of individual missingness (>3%), insufficient 
sample replication (IBD <0.8), non-European ancestry (assessed by multidimensional scaling 
analysis and compared with Hapmap II) and cryptic relatedness (IBD > 0.1). SNPs were 
excluded based on minor allele frequency (<1%), call rate (<95%) or evidence for violations of 
Hardy-Weinberg equilibrium (P < 5E-7). Imputation was conducted by the ALSPAC team using 
Impute V2.2.2 against the 1000 genomes reference panel (Phase 1, Version 3: all polymorphic 
SNPs excluding singletons), using all 2186 reference haplotypes (including non-Europeans). 
SNPs were subsequently filtered based on minor allele frequency (<1%) and imputation quality 
(INFO<0.8). Following quality control and limiting individuals to one child per family, genetic 
data were available for N=7975. 
Genome-wide association study (GWAS) summary statistics used to generate PRS were filtered 
to remove SNPs that were palindromic, insertions/deletions, non-autosomal, INFO score <0.8, 
missing in N>1 study and duplicates (https://github.com/ricanney). Depression results for 
23andme (75,607 cases and 231,747 controls) (1) and the other samples included in the latest 
depression GWAS (2) (PGC29, deCODE, Generation Scotland, GERA, iPSYCH, and UK Biobank) 
were meta-analyzed in METAL. PRS were generated in ALSPAC using PRSice (3); SNPs were 
clumped with an R2 threshold of 0.1 and a distance threshold of 1000kb and excluding the 
extended major histocompatibility complex (MHC; chromosome 6: 26-33Mb) due to the high 
linkage disequilibrium (LD) within this region.  
Selecting the number of trajectories 
To select the number of classes for the two growth mixture models (GMMs), we initially 
modelled a single k-class solution, modelling subsequent k+1 solutions until the optimum 
solution was reached. Residual variances were fixed across measurement points. Each model 
was run with 5000 random starting values and 500 optimizations (STARTS = 5000 500 in 
Mplus) (4) and included both linear and quadratic change. Fit statistics are presented in 
Supplementary Table 2. Both the intercept and quadratic variance was fixed to zero because for 
models with more than two classes these explained the variation in the intercept and quadratic 
(i.e. was close to zero). Model fit significantly improved, as indicated by the fall in loglikelihood 
2 
 
value, sample size adjusted Bayesian information criterion as well as the Bootstrapped 
Likelihood Ratio Test, from the one to six class solutions. However, the six class two small 
classes (≤2%). Current guidance (5) suggests that if fit indices are similar (size adjusted 
Bayesian information criterion being the preferred index), unless there are strong theoretical 
reasons for preferring a particular solution, the more parsimonious solution i.e. with fewer 
classes is preferred. Because this is the first study to our knowledge to investigate irritability 
trajectories across childhood and adolescence, there is no clear theoretical guidance on how 
many or what shaped trajectories are to be expected. The five class solution was therefore 
selected and this also showed high classification accuracy (entropy = 0.94). 
Inverse probability weighting  
Inverse probability weighting (IPW) was used to assess the impact of missing genetic data and 
has been recommended over alternative methods such as multiple imputation in situations 
where whole blocks of data are missing for a large proportion of individuals (6). As described 
elsewhere (7), weights were derived from a logistic regression analysis of missing genetic data 
for those in the ‘core’ ALSPAC sample (N = 7495/13793) for a set of measures assessed in 
pregnancy: child gender, maternal age and child birth weight. The analyses were rerun using 
IPW to address any potential bias caused by only a subsample having genetic data and revealed 
a similar pattern of results (see Supplementary Table 5). 
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Supplementary Table 1. Irritability measure descriptive statistics 
  Cumulative frequency (%) Average 
  0 0-1 0-2 0-3 0-4 0-5 0-6 Mean (SD) 
Age 7 years 7 months  (N=6975) 76.36 87.17 93.72 97.12 98.39 99.20 100 0.48 (1.06) 
Age 10 years 8 months (N=7180) 75.84 86.31 93.30 96.85 97.97 98.86 100 0.51 (1.12) 
Age 13 years 10 months (N=6646) 78.33 87.30 93.73 97.14 98.09 98.92 100 0.46 (1.09) 
Age 15 years 6 months (N=4415) 76.81 86.14 92.46 96.44 97.40 98.53 100 0.52 (1.18) 
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Supplementary Table 2. Model fit indices for irritability growth mixture models  
 LL Free 
parameters 
BIC ssaBIC Smallest 
class 
Entropy VLMR-LRT  
p value 
BLRT  
p value 
1 class -37494.52 5 75033.93 75018.04 100%      
2 classes -33448.78 9 66978.35 66949.75 8% 0.96 <0.0001  <0.0001  
3 classes -32326.50 13 64769.70 64728.39 6% 0.96 0.0599  <0.0001  
4 classes -30994.71 17 62142.04 62088.02 3% 0.95 0.0009  <0.0001  
5 classes* -30023.11 21 60234.75 60168.02 2% 0.94 0.0001  <0.0001  
6 classes** -29399.46 24 59014.39 58938.12 2% 0.94 0.0004 *** <0.0001 *** 
LL=Loglikelihood; BIC= Bayesian Information Criteria; ssa= sample size adjusted;  
VLMR-LRT=Vuong-Lo-Mendell-Rubin Likelihood Ratio Rest; BLRT=Bootstrapped 
Likelihood Ratio Rest. *Final model. **Slope variance also fixed to zero variance because 
the slope variance was close to zero (i.e. classes explained the variation in the slope). 
***Compared to a 5 class model where slope variance was also fixed to zero. 
 
 
Supplementary Table 3. Multivariate associations between genetic risk and trajectories 
 ADHD PRS Depression PRS 
 OR 95% CI p OR 95% CI p 
Childhood-onset irritability       
  Decreasing 1.05 (0.91, 1.20) 0.524 1.11 (0.96, 1.28) 0.147 
  Late-childhood limited 1.15 (1.00, 1.33) 0.053 0.92 (0.81, 1.04) 0.173 
  High-persistent 1.32 (1.09, 1.60) 0.005 0.97 (0.79, 1.17) 0.726 
Adolescent-onset irritability       
  Increasing 1.26 (1.09, 1.45) 0.002 1.17 (1.01, 1.34) 0.032 
Low trajectory as reference. ADHD=attention-deficit/hyperactivity disorder, PRS = polygenic 
risk score 
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Supplementary Table 4. Associations between genetic risk and trajectories using IPW 
 Original result Core sample Core sample: IPW 
ADHD PRS OR 95% CI p OR 95% CI p OR 95% CI p 
Decreasing 1.06 (0.92, 1.22) 0.425 1.09 (0.95-1.26) 0.221 1.10 (0.95-1.28) 0.201 
Late-childhood limited 1.14 (0.99, 1.32) 0.071 1.14 (0.98-1.32) 0.079 1.13 (0.98-1.31) 0.093 
High-persistent 1.31 (1.09, 1.58) 0.005 1.30 (1.08-1.57) 0.006 1.29 (1.07-1.56) 0.007 
Increasing 1.28 (1.11, 1.48) 0.001 1.28 (1.11-1.49) 0.001 1.31 (1.13-1.53) <0.001 
 Original result Core sample Core sample: IPW 
Depression PRS OR 95% CI p OR 95% CI p OR 95% CI p 
Decreasing 1.12 (0.97, 1.29) 0.126 1.14 (0.99-1.31) 0.075 1.16 (1.00-1.34) 0.043 
Late-childhood limited 0.93 (0.82, 1.06) 0.266 0.93 (0.82-1.06) 0.298 0.94 (0.83-1.07) 0.382 
High-persistent 1.00 (0.82, 1.21) 0.992 1.03 (0.85-1.24) 0.763 1.03 (0.85-1.25) 0.732 
Increasing 1.20 (1.05, 1.38) 0.009 1.21 (1.051.40) 0.009 1.24 (1.07-1.44) 0.004 
Low trajectory as reference. IPW= inverse probability weighting. ADHD=attention-deficit/hyperactivity disorder, PRS = polygenic risk score 
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Supplementary Table 5. Association between ADHD and depression genetic risk scores and 
irritability trajectories, controlling for gender 
 ADHD PRS Depression PRS 
 OR 95% CI p OR 95% CI p 
Childhood-onset irritability       
  Decreasing 1.06 (0.92, 1.22) 0.401 1.14 (0.99, 1.32) 0.121 
  Late-childhood limited 1.14 (0.99, 1.32) 0.068 0.93 (0.82, 1.06) 0.281 
  High-persistent 1.32 (1.09, 1.59) 0.004 1.01 (0.83, 1.22) 0.958 
Adolescent-onset irritability       
  Increasing 1.28 (1.11, 1.48) 0.001 1.20 (1.05, 1.38) 0.009 
Low trajectory as reference. ADHD=attention-deficit/hyperactivity disorder, PRS = polygenic 
risk score 
 
Supplementary Table 6. Association between childhood ADHD and adolescent depression 
diagnoses and irritability trajectories, controlling for gender 
 Childhood ADHD Adolescent depression 
 OR 95% CI p OR 95% CI p 
Childhood-onset irritability       
  Decreasing 29.70 (14.81-59.55) <0.001 2.41 (0.92-6.34) 0.074 
  Late-childhood limited 19.13 (9.21-39.73) <0.001 2.01 (0.66-6.17) 0.220 
  High-persistent 101.09 (53.05-192.64) <0.001 7.68 (3.27-18.00) <0.001 
Adolescent-onset irritability       
  Increasing 6.40 (2.05-20.04) 0.001 4.73 (2.26-9.90) <0.001 
Low trajectory as reference. ADHD=attention-deficit/hyperactivity disorder. OR for childhood 
ADHD = likelihood of being in irritability trajectory class for ADHD diagnosis vs. no ADHD 
diagnosis; gender predicting irritability trajectory class. OR for adolescent depression = 
likelihood of having adolescent depression for given irritability trajectory class vs low 
irritability trajectory class; gender predicting depression. 
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Supplementary Table 7. Association between ADHD and depression genetic risk scores and 
irritability trajectories, excluding diagnoses 
 Full sample  
(N=5559) 
Excluding childhood ADHD 
(N=4892) 
ADHD PRS OR 95% CI p OR 95% CI p 
Decreasing 1.06 (0.92, 1.22) 0.425 1.08 (0.92-1.25) 0.324 
Late-childhood limited 1.14 (0.99, 1.32) 0.071 1.11 (0.95-1.29) 0.208 
High-persistent 1.31 (1.09, 1.58) 0.005 1.31 (1.04-1.64) 0.021 
Increasing 1.28 (1.11, 1.48) 0.001 1.21 (1.03-1.42) 0.021 
 Full sample  
(N=5559) 
Excluding adolescent 
depression (N=3718) 
Depression PRS OR 95% CI p OR 95% CI p 
Decreasing 1.12 (0.97, 1.29) 0.126 1.13 (0.95-1.34) 0.160 
Late-childhood limited 0.93 (0.82, 1.06) 0.266 0.88 (0.76-1.02) 0.089 
High-persistent 1.00 (0.82, 1.21) 0.992 1.06 (0.81-1.40) 0.659 
Increasing 1.20 (1.05, 1.38) 0.009 1.16 (0.97-1.39) 0.109 
Low trajectory as reference. ADHD=attention-deficit/hyperactivity disorder, PRS = polygenic 
risk score 
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Supplementary Figure 1. Participation rates 
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Supplementary Figure 2. Polygenic risk score associations using a range of p-value thresholds 
from the discovery sample 
a) Attention-deficit/hyperactivity disorder polygenic risk scores 
 
b) Depression polygenic risk scores 
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Supplementary Figure 3. Mean ADHD and depression genetic risk score by irritability trajectories, with 95% confidence intervals 
a) boys 
 
b) girls 
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Supplementary Figure 4. Estimated prevalence of diagnoses by irritability trajectories, with 95% confidence intervals 
a) Boys: childhood b) Boys: Adolescence 
  
c) Girls: childhood d) Girls: Adolescence 
  
